Annis, D. Allen
2Aileron Therapeutics, Inc., Watertown, Massachusetts.
4 papers on CoChatORCID 0000-0002-3953-4590
Most cited papers
- Verified
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
Carvajal, L. A., Neriah, D. B., Senecal, A., Benard, L., Thiruthuvanathan, V., Yatsenko, T., Narayanagari, S.-R., Wheat, J. C., Todorova, T. I., Mitchell, K., et al. (2018) · Science Translational Medicine
Cancer-related Molecular PathwaysAcute Myeloid Leukemia Research
Cited by 249
- Verified
Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity
Zhou, X., Singh, M., Sanz Santos, G., Guerlavais, V., Carvajal, L. A., Aivado, M., Zhan, Y., Oliveira, M. M. S., Westerberg, L. S., Annis, D. A., et al. (2021) · Cancer Discovery
Cancer Immunotherapy and BiomarkersCancer-related Molecular Pathways
Cited by 169
- Verified
Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53
Saleh, M. N., Patel, M. R., Bauer, T. M., Goel, S., Falchook, G. S., Shapiro, G. I., Chung, K. Y., Infante, J. R., Conry, R. M., Rabinowits, G., et al. (2021) · Clinical Cancer Research
Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer
Cited by 159
- Verified
Exploring new targets and chemical space with affinity selection-mass spectrometry
Prudent, R., Annis, D. A., Dandliker, P. J., Ortholand, J.-Y., & Roche, D. (2020) · Nature Reviews Chemistry
Mass Spectrometry Techniques and ApplicationsChemical Synthesis and Analysis
Cited by 104
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free